These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 29281924)

  • 1. One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells.
    Eldehna WM; El-Naggar DH; Hamed AR; Ibrahim HS; Ghabbour HA; Abdel-Aziz HA
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):309-318. PubMed ID: 29281924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Crystal Study, and Anti-Proliferative Activity of Some 2-Benzimidazolylthioacetophenones towards Triple-Negative Breast Cancer MDA-MB-468 Cells as Apoptosis-Inducing Agents.
    Abdel-Aziz HA; Eldehna WM; Ghabbour H; Al-Ansary GH; Assaf AM; Al-Dhfyan A
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
    Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
    Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Thiazolidinone/Thiazolo[3,2-
    El-Naggar M; Eldehna WM; Almahli H; Elgez A; Fares M; Elaasser MM; Abdel-Aziz HA
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29895744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel racemosin B derivatives as new therapeutic agents for aggressive breast cancer.
    Xiao X; Xu M; Yang C; Yao Y; Liang LN; Ed Chung P; Long Q; Zacksenhaus E; He Z; Liu S; Ben-David Y
    Bioorg Med Chem; 2018 Dec; 26(23-24):6096-6104. PubMed ID: 30471828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents.
    Eldehna WM; Almahli H; Al-Ansary GH; Ghabbour HA; Aly MH; Ismael OE; Al-Dhfyan A; Abdel-Aziz HA
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):600-613. PubMed ID: 28173708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole-Indole Conjugates as Anticancer CDK Inhibitors.
    Al-Warhi T; El Kerdawy AM; Aljaeed N; Ismael OE; Ayyad RR; Eldehna WM; Abdel-Aziz HA; Al-Ansary GH
    Molecules; 2020 Apr; 25(9):. PubMed ID: 32349307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro targeting of colon cancer cells using spiropyrazoline oxindoles.
    Nunes RC; Ribeiro CJA; Monteiro Â; Rodrigues CMP; Amaral JD; Santos MMM
    Eur J Med Chem; 2017 Oct; 139():168-179. PubMed ID: 28800455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfamic acid promoted one-pot three-component synthesis and cytotoxic evaluation of spirooxindoles.
    Kamal A; Babu KS; Vishnu Vardhan MV; Hussaini SM; Mahesh R; Shaik SP; Alarifi A
    Bioorg Med Chem Lett; 2015; 25(10):2199-202. PubMed ID: 25870131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New (E)-1-alkyl-1H-benzo[d]imidazol-2-yl)methylene)indolin-2-ones: Synthesis, in vitro cytotoxicity evaluation and apoptosis inducing studies.
    Sharma P; Thummuri D; Reddy TS; Senwar KR; Naidu VGM; Srinivasulu G; Bharghava SK; Shankaraiah N
    Eur J Med Chem; 2016 Oct; 122():584-600. PubMed ID: 27448916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, combinatorial synthesis and biological evaluations of novel 3-amino-1'-((1-aryl-1H-1,2,3-triazol-5-yl)methyl)-2'-oxospiro[benzo[a] pyrano[2,3-c]phenazine-1,3'-indoline]-2-carbonitrile antitumor hybrid molecules.
    Lu Y; Wang L; Wang X; Xi T; Liao J; Wang Z; Jiang F
    Eur J Med Chem; 2017 Jul; 135():125-141. PubMed ID: 28441581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of spiro[cyclopropane-1,3'-indolin]-2'-ones as potential anticancer agents.
    Reddy CN; Nayak VL; Mani GS; Kapure JS; Adiyala PR; Maurya RA; Kamal A
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4580-6. PubMed ID: 26330077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-pot mild and efficient synthesis of [1,3]thiazino[3,2-a]indol-4-ones and their anti-proliferative activity.
    Rhodes S; Short S; Sharma S; Kaur R; Jha M
    Org Biomol Chem; 2019 Apr; 17(16):3914-3920. PubMed ID: 30942251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H2O-mediated isatin spiro-epoxide ring opening with NaCN: Synthesis of novel 3-tetrazolylmethyl-3-hydroxy-oxindole hybrids and their anticancer evaluation.
    Sharma P; Senwar KR; Jeengar MK; Reddy TS; Naidu VG; Kamal A; Shankaraiah N
    Eur J Med Chem; 2015 Nov; 104():11-24. PubMed ID: 26413726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Spirocyclohexadienones as New Anti-Migratory Compounds in Triple- Negative Breast Cancer Cell Migration.
    Altei WF; Pachane BC; Martins LJ; Gomes RC; Santos RN; Fernandes DC; Selistre-de-Araújo HS; Coelho F; Andricopulo AD
    Anticancer Agents Med Chem; 2021; 21(14):1901-1910. PubMed ID: 33292143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies.
    Senwar KR; Sharma P; Reddy TS; Jeengar MK; Nayak VL; Naidu VG; Kamal A; Shankaraiah N
    Eur J Med Chem; 2015 Sep; 102():413-24. PubMed ID: 26301558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and structure-activity relationship studies of a focused library of pyrimidine moiety with anti-proliferative and anti-metastasis activities in triple negative breast cancer.
    Yao D; Zhou Y; Zhu L; Ouyang L; Zhang J; Jiang Y; Zhao Y; Sun D; Yang S; Yu Y; Wang J
    Eur J Med Chem; 2017 Nov; 140():155-171. PubMed ID: 28923383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo.
    Hsieh MT; Chang LC; Hung HY; Lin HY; Shih MH; Tsai CH; Kuo SC; Lee KH
    Eur J Med Chem; 2017 May; 131():141-151. PubMed ID: 28319780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
    Luo Y; Wu W; Zha D; Zhou W; Wang C; Huang J; Chen S; Yu L; Li Y; Huang Q; Zhang J; Zhang C
    Bioorg Med Chem Lett; 2021 Sep; 47():128230. PubMed ID: 34186178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
    Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B
    Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.